Postpartum venous thromboembolism readmissions in the United States

American Journal of Obstetrics and Gynecology
Timothy WenAlexander M Friedman

Abstract

There are limited data on when postpartum readmissions for thromboembolism occur after delivery hospitalizations on a population basis in the United States. We sought to characterize risk factors for and timing of postpartum venous thromboembolism readmission after delivery hospitalization discharge. The Healthcare Cost and Utilization Project Nationwide Readmissions Database for calendar years 2013 and 2014 was used to perform a retrospective cohort study evaluating risk for readmission for venous thromboembolism within 60 days of discharge from a delivery hospitalization. Risks for deep vein thrombosis and pulmonary embolism were individually assessed. Obstetric, medical, demographic, and hospital factors associated with postpartum readmission for venous thromboembolism were analyzed. Risk was characterized as odds ratios with 95% confidence intervals. Both unadjusted and adjusted analyses were performed. Adjusted analyses included relevant obstetric, medical, demographic, and hospital factors within logistic regression models. From Jan. 1 through Oct. 31 in 2013 and 2014, 6,269,641 delivery hospitalizations were included in the analysis. In all, 2975 cases of readmission for any venous thromboembolism were identified (4.7 pe...Continue Reading

Citations

Dec 1, 2018·BJOG : an International Journal of Obstetrics and Gynaecology·A J ButwickN Guo
Mar 29, 2019·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Arielle FeinAlexander M Friedman
Dec 7, 2019·Obstetrics and Gynecology·Mirella MouradNoelia Zork
Jan 18, 2020·Paediatric and Perinatal Epidemiology·Katherine P Himes, Lisa M Bodnar
Mar 15, 2019·Obstetrics and Gynecology·Timothy WenAlexander M Friedman
Aug 15, 2019·American Journal of Perinatology·Timothy WenAlexander M Friedman
Sep 2, 2020·Gynecologic Oncology·Tiffany Y SiaJason D Wright
Mar 10, 2021·BJOG : an International Journal of Obstetrics and Gynaecology·A CiociR Rattan
Jul 6, 2021·American Journal of Obstetrics and Gynecology·Logan MauneyMark A Clapp
Jul 17, 2021·Current Opinion in Hematology·Cha HanJing-Fei Dong
Nov 29, 2021·American Journal of Obstetrics and Gynecology·UNKNOWN Society for Maternal-Fetal Medicine (SMFM)UNKNOWN Patient Safety and Quality Committee. Electronic address: smfm@smfm.org
Dec 18, 2021·American Journal of Obstetrics & Gynecology MFM·Rajesh ReddyMark A Clapp

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Obstetrics and Gynecology
Gloria TooAlexander M Friedman
The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Timothy WenAlexander M Friedman
© 2022 Meta ULC. All rights reserved